Exhibitors and Sponsors Sample Clauses

Exhibitors and Sponsors. Code of Conduct for TAPA EMEA events Since its foundation in 1999, TAPA EMEA has become an influential and well-respected organization of manufacturers of high value goods, their distributors, and their transport service providers. As time has progressed, TAPA EMEA has welcomed members from other sectors including insurance, LEA and security service providers. In addition, TAPA EMEA has welcomed support from exhibitors and sponsors at their conferences and other events. TAPA EMEA will accept, under the rules mentioned below, its members and companies that are supply chain security service providers, as exhibitors and or sponsors.
Sample 1
AutoNDA by SimpleDocs
Exhibitors and Sponsors. MUST register online.
Sample 1
Exhibitors and Sponsors. Here are just a few of the organizations that participated as exhibitors and/or sponsors during the 2012 Forums: Abiomed Accumetrics Actelion Pharmaceuticals Aerocrine Agendia Alcon Laboratories Alere Altegra Health Amarin Pharma American Regent Ameritox Amgen Amylin Pharmaceuticals Astellas Pharma US Authentidate Auxilium Pharmaceuticals Bayer Healthcare Pharmaceuticals BioRx Biogen Idec Bioventus Boehringer Ingelheim Pharmaceuticals Xxxxxxx-Xxxxx Squibb Company Celleration Coram Specialty Infusion Services Dendreon Xxxxxxx Health Eisai Express Scripts First Call Pharmacy Forest Pharmaceuticals Genentech Genomic Health Gilead Sciences Glaukos Corporation GlaxoSmithKline HRA Healthcare Research & Analytics Halt Medical Xxxxx, Inc. Healthpoint Biotherapeutics Hill-Rom Respiratory Care Hologic Home Instead Senior Care Horizon Pharma ICLOPS IPSEN Impax Pharmaceuticals ImpediMed Xxxxxxx Pharmaceuticals KCI Kindred Healthcare LabCorp LifeScan & Animas Corporation LipoScience Medical Review Institute of America Medtronic Merck & Co. Millennium Laboratories Mission Pharmacal Company Myriad Genetic Laboratories NeuroMetrix NextWave Pharmaceuticals Novartis Pharmaceuticals Novasys Medical Novo Nordisk OncoMed, The Oncology Company Otsuka America Pharmaceutical PerkinElmer Prometheus Laboratories Purdue Pharma L.P. RCM Healthcare Services Registry of Physician Specialists ResMed SI-BONE Salix Pharmaceuticals SeniorBridge Sequenom Center for Molecular Medicine Xxxxx & Nephew Tandem Diabetes Care Terumo BCT Teva Teva Oncology Teva Pharmaceuticals United Seating & Mobility Uroplasty Valeritas Veracyte Verinata Health Vivus Walgreens Xxxxxx Pharmaceuticals WellDyne
Sample 1
Exhibitors and Sponsors acknowledge that in the event that they do not have individual cover for an Event, that the Organiser can arrange for public liability cover for the period of an Event on behalf of the Exhibitor or Sponsor at a cost to the Exhibitor or Sponsor. It is the responsibility of the Exhibitor, Advertiser or Sponsor to request in writing such cover from the Organiser no later than 14 days prior to the commencement date of an Event.
Sample 1
Exhibitors and Sponsors. Section 3.24. Penciled-in Dates
Sample 1
Exhibitors and Sponsors. Except as set forth therein, Schedule 3.23 sets forth a complete and correct list of the 20 largest exhibitors and sponsors of each of the Shows most recently held and indicates for each the total exhibit or sponsorship fee payable in respect thereof.
Sample 1

Related to Exhibitors and Sponsors

  • Subcontractors and Unaffiliated Third Parties (a) The Escrow Agent may, without further consent of any party hereto, subcontract with (i) any of its affiliates, or (ii) unaffiliated subcontractors for such services as may be required from time to time (e.g., lost stockholder searches, escheatment, telephone and mailing services); provided, however, that the Escrow Agent (i) shall be fully responsible for the acts and omissions of its affiliate as it is for its own acts and omissions and (ii) shall not be liable for the acts and omissions of any subcontractor absent willful misconduct, bad faith or gross negligence of the Escrow Agent in the selection of such subcontractor (each as determined by a final, non-appealable judgment of a court of competent jurisdiction).

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Management of Company 5.1.1 The Members, within the authority granted by the Act and the terms of this Agreement shall have the complete power and authority to manage and operate the Company and make all decisions affecting its business and affairs.

  • Indemnification of Company, Directors and Officers and Selling Stockholders Each Underwriter severally agrees to indemnify and hold harmless the Company, its directors, each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, and each Selling Stockholder and each person, if any, who controls any Selling Stockholder within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), including the Rule 430A Information, the General Disclosure Package or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Underwriter Information.

  • Officers, Directors and Employees JML has one officer and director, namely Xxxxx Polos, and has no employees.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!